EE05380B1 - FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid - Google Patents

FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid

Info

Publication number: EE05380B1
Authority: EE; Estonia
Prior art keywords: pharmaceutical; acidandcontaining; phenolethanolamine; preparation; crystalline form
Prior art date: 2001-06-28

Application number

EEP200400007A

Other languages

English (en)

Estonian (et)

Inventor

Antoine�Caron

Olivier�Monnier

Sabrina�Obert

J�rome�Roche

Isabelle�Ziri

Original Assignee

Sanofi-Synthlabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-28

Filing date

2002-06-27

Publication date

2011-02-15

2002-06-27 Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo

2004-02-16 Publication of EE200400007A publication Critical patent/EE200400007A/xx

2011-02-15 Publication of EE05380B1 publication Critical patent/EE05380B1/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EEP200400007A 2001-06-28 2002-06-27 FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid EE05380B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0108562A FR2826651B1 (fr)	2001-06-28	2001-06-28	Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
PCT/FR2002/002235 WO2003002510A1 (fr)	2001-06-28	2002-06-27	Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Publications (2)

Publication Number	Publication Date
EE200400007A EE200400007A (et)	2004-02-16
EE05380B1 true EE05380B1 (et)	2011-02-15

Family

ID=8864888

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200400007A EE05380B1 (et)	2001-06-28	2002-06-27	FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid

Country Status (29)

Country	Link
US (1)	US6992211B2 (de)
EP (1)	EP1404641B1 (de)
JP (2)	JP4171413B2 (de)
KR (1)	KR100869017B1 (de)
CN (1)	CN1269797C (de)
AR (1)	AR034648A1 (de)
AT (1)	ATE403642T1 (de)
AU (1)	AU2002333942B2 (de)
BR (1)	BR0210661A (de)
CA (1)	CA2450213C (de)
CY (1)	CY1110099T1 (de)
CZ (1)	CZ301450B6 (de)
DE (1)	DE60228088D1 (de)
DK (1)	DK1404641T3 (de)
EE (1)	EE05380B1 (de)
ES (1)	ES2307798T3 (de)
FR (1)	FR2826651B1 (de)
HU (1)	HUP0401229A3 (de)
IL (2)	IL159134A0 (de)
MX (1)	MXPA03011742A (de)
NO (1)	NO331169B1 (de)
NZ (1)	NZ530140A (de)
PL (1)	PL206680B1 (de)
PT (1)	PT1404641E (de)
SI (1)	SI1404641T1 (de)
SK (1)	SK287355B6 (de)
TW (1)	TWI286129B (de)
WO (1)	WO2003002510A1 (de)
ZA (1)	ZA200309512B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2826651B1 (fr) *	2001-06-28	2005-09-02	Sanofi Synthelabo	Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (de) *	2004-07-09	2006-02-08	Sanofi-Aventis	Verwendung von Phenyläthanolaminotetralinen zur Herstellung von Anxiolytika
FR2890862B1 (fr) *	2005-09-19	2008-01-25	Sanofi Aventis Sa	Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
EP3397765B1 (de)	2015-12-30	2023-02-01	Bio-Rad Laboratories, Inc.	Verfahren zur quantifizierung von wildtyp- und mutanten-fragmenten in einer nukleinsäureprobe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5235103A (en) *	1987-08-12	1993-08-10	Sanofi	Process for the preparation of phenylethanolaminotetralins
ES2067483T3 (es) *	1987-08-12	1995-04-01	Sanofi Sa	Procedimiento para la o-alquilacion de n-(hidroxi)aralquilfeniletanolaminas.
US5198586A (en) *	1987-08-12	1993-03-30	Sanofi	Process for the preparation of phenylethanolaminotetralins
US5202466A (en)	1988-06-14	1993-04-13	Sanofi	2-amino-7-hydroxytetraline ethers
FR2648042B1 (fr) *	1989-06-13	1994-06-10	Midy Spa	Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
US5312961A (en) *	1989-02-14	1994-05-17	Elf Sanofi	2-amino-7-hydroxytetralin carboxylalkyl ethers
FR2643076B1 (fr) *	1989-02-14	1991-06-21	Midy Spa	Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2669821A1 (fr) *	1990-12-04	1992-06-05	Sanofi Sa	Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
FR2826651B1 (fr) *	2001-06-28	2005-09-02	Sanofi Synthelabo	Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

2001
- 2001-06-28 FR FR0108562A patent/FR2826651B1/fr not_active Expired - Fee Related
2002
- 2002-06-27 HU HU0401229A patent/HUP0401229A3/hu unknown
- 2002-06-27 SK SK1593-2003A patent/SK287355B6/sk not_active IP Right Cessation
- 2002-06-27 BR BR0210661-2A patent/BR0210661A/pt not_active Application Discontinuation
- 2002-06-27 TW TW091114166A patent/TWI286129B/zh not_active IP Right Cessation
- 2002-06-27 AT AT02780917T patent/ATE403642T1/de active
- 2002-06-27 ES ES02780917T patent/ES2307798T3/es not_active Expired - Lifetime
- 2002-06-27 AU AU2002333942A patent/AU2002333942B2/en not_active Ceased
- 2002-06-27 SI SI200230728T patent/SI1404641T1/sl unknown
- 2002-06-27 KR KR1020037016946A patent/KR100869017B1/ko not_active Expired - Fee Related
- 2002-06-27 MX MXPA03011742A patent/MXPA03011742A/es active IP Right Grant
- 2002-06-27 JP JP2003508694A patent/JP4171413B2/ja not_active Expired - Fee Related
- 2002-06-27 EP EP02780917A patent/EP1404641B1/de not_active Expired - Lifetime
- 2002-06-27 PT PT02780917T patent/PT1404641E/pt unknown
- 2002-06-27 US US10/480,427 patent/US6992211B2/en not_active Expired - Fee Related
- 2002-06-27 WO PCT/FR2002/002235 patent/WO2003002510A1/fr not_active Ceased
- 2002-06-27 DK DK02780917T patent/DK1404641T3/da active
- 2002-06-27 EE EEP200400007A patent/EE05380B1/xx not_active IP Right Cessation
- 2002-06-27 CA CA2450213A patent/CA2450213C/en not_active Expired - Fee Related
- 2002-06-27 DE DE60228088T patent/DE60228088D1/de not_active Expired - Lifetime
- 2002-06-27 IL IL15913402A patent/IL159134A0/xx unknown
- 2002-06-27 PL PL368055A patent/PL206680B1/pl not_active IP Right Cessation
- 2002-06-27 CN CNB028130952A patent/CN1269797C/zh not_active Expired - Fee Related
- 2002-06-27 CZ CZ20033531A patent/CZ301450B6/cs not_active IP Right Cessation
- 2002-06-27 NZ NZ530140A patent/NZ530140A/en not_active IP Right Cessation
- 2002-06-27 AR ARP020102421A patent/AR034648A1/es active IP Right Grant
2003
- 2003-11-30 IL IL159134A patent/IL159134A/en not_active IP Right Cessation
- 2003-12-08 ZA ZA200309512A patent/ZA200309512B/xx unknown
- 2003-12-29 NO NO20035839A patent/NO331169B1/no not_active IP Right Cessation
2008
- 2008-07-08 JP JP2008178049A patent/JP4799592B2/ja not_active Expired - Fee Related
- 2008-09-24 CY CY20081101044T patent/CY1110099T1/el unknown

Also Published As

Publication number	Publication date
CZ20033531A3 (en)	2004-04-14
TWI286129B (en)	2007-09-01
JP2004530725A (ja)	2004-10-07
EE200400007A (et)	2004-02-16
ATE403642T1 (de)	2008-08-15
DK1404641T3 (da)	2008-12-08
HUP0401229A3 (en)	2008-03-28
MXPA03011742A (es)	2004-07-01
KR20040017817A (ko)	2004-02-27
PL368055A1 (en)	2005-03-21
US20040180953A1 (en)	2004-09-16
JP2009029804A (ja)	2009-02-12
NO331169B1 (no)	2011-10-24
CA2450213C (en)	2011-02-15
US6992211B2 (en)	2006-01-31
IL159134A (en)	2009-07-20
PT1404641E (pt)	2008-09-22
CY1110099T1 (el)	2015-01-14
CN1269797C (zh)	2006-08-16
CN1522241A (zh)	2004-08-18
DE60228088D1 (de)	2008-09-18
EP1404641B1 (de)	2008-08-06
NO20035839L (no)	2004-03-01
JP4799592B2 (ja)	2011-10-26
FR2826651A1 (fr)	2003-01-03
AR034648A1 (es)	2004-03-03
SK15932003A3 (sk)	2004-05-04
CA2450213A1 (en)	2003-01-09
KR100869017B1 (ko)	2008-11-17
IL159134A0 (en)	2004-05-12
PL206680B1 (pl)	2010-09-30
ZA200309512B (en)	2004-12-08
ES2307798T3 (es)	2008-12-01
FR2826651B1 (fr)	2005-09-02
HK1063621A1 (zh)	2005-01-07
JP4171413B2 (ja)	2008-10-22
BR0210661A (pt)	2004-10-05
NZ530140A (en)	2005-05-27
HUP0401229A2 (hu)	2004-10-28
CZ301450B6 (cs)	2010-03-03
AU2002333942B2 (en)	2008-02-28
SK287355B6 (sk)	2010-08-09
EP1404641A1 (de)	2004-04-07
WO2003002510A1 (fr)	2003-01-09
SI1404641T1 (sl)	2008-10-31

Legal Events

Date	Code	Title	Description
2005-02-15	HC1A	Change of owner name
2013-02-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20120627

Publication	Publication Date	Title
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
NO20024175L (no)	2002-10-29	Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
ATE296619T1 (de)	2005-06-15	Feste orale dosierungsform von simethicon
NO20031692D0 (no)	2003-04-11	Fremgangsmåte for fremstilling av pulverformuleringer
EE200200486A (et)	2004-02-16	Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
EP1383518A4 (de)	2005-11-09	Orale abgabe von makromolekülen
HUP0402338A3 (en)	2008-10-28	Spiro-hydantoin compounds, their use as anti-inflammatory agents, pharmaceutical compositions containing them and intermediates for preparing them
DE60206889D1 (de)	2005-12-01	Pharmazeutische formulierung enthaltend bicalutamid
EP1461044A4 (de)	2007-06-13	Pharmazeutische zusammensetzungen mit aktiven vitamin-d-verbindungen
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
NO20040125L (no)	2004-01-12	Enterale formuleringer
DK1414409T3 (da)	2007-06-11	Stabiliseret oral suspensionsformulering
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
IS7051A (is)	2003-11-26	Lyfjasamsetningar
ATE324883T1 (de)	2006-06-15	Pharmazeutische zusammensetzung enthaltend lumiracoxib
EE200300501A (et)	2003-12-15	Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
IS6021A (is)	2001-10-20	Lyfjasamsetningar sem innihalda sítalópram
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
EE200200252A (et)	2003-06-16	Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
EE200300468A (et)	2004-02-16	Pravastatiini stabiilne farmatseutiline kompositsioon
ITMI20001695A0 (it)	2000-07-25	Procedimento per la preparazione di composizioni organico-sili-coniche.
EE200300548A (et)	2004-02-16	Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
NO20033073D0 (no)	2003-07-04	Farmasöytisk sammensetning inneholdende citalopram
NO20042074L (no)	2004-05-19	Makrolider inneholdende farmasoytiske sammensetninger

EE05380B1 - FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid - Google Patents